COVERAGE
Amgen Tells Full Fed. Circ. Antibody IP Ax Dooms Biologics
April 15, 2021
Read time: 2 min
You may also like
-
Capabilities
Main /
Capabilities- Antitrust
- Artificial Intelligence
- Business Restructuring
- Corporate & Transactional
- Crisis Management
- Data, Privacy & Cybersecurity
- Employee Benefits & Executive Compensation
- Employment
- Government & Lobbying Strategies
- Government Contracts
- Intellectual Property
- International Trade
- Investment Management
- Litigation & Dispute Resolution
- Mergers & Acquisitions
- Private Client
- Real Estate
- Shareholder Activism
- Strategic Solutions
- Sustainability, Impact & ESG
- Tax
- Trade Secrets
- White-Collar Defense & Government Investigations
- Regional Markets
Capabilities -
Insights
main /
InsightsFeatured
Categories